Publicaciones en las que colabora con José Antonio Páramo Fernández (96)

2023

  1. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

  2. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  3. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Impact of the mutation profile on thrombotic risk in cancer patients

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 93-99

2021

  1. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke

    Journal of Neuroinflammation, Vol. 18, Núm. 1

  2. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

  3. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

    Frontiers in Neurology, Vol. 12

  4. Molecular and Cellular Mechanisms of Delayed Fracture Healing in Mmp10 (Stromelysin 2) Knockout Mice

    Journal of Bone and Mineral Research, Vol. 36, Núm. 11, pp. 2203-2213

2020

  1. Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage

    Scientific Reports, Vol. 10, Núm. 1

  2. Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)

    Journal of Extracellular Vesicles, Vol. 9, Núm. 1

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  4. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

  5. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes

    Translational Stroke Research, Vol. 10, Núm. 4, pp. 389-401

  6. New mechanisms in vein thrombosis: Immunothrombosis

    Medicina Clinica, Vol. 153, Núm. 2, pp. 78-81

  7. Risk factors and impact of portal vein thrombosis in liver transplantation

    Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 6, pp. 437-444

  8. Surgical thromboprophylaxis in daily urologic surgery: Beyond bridge therapy

    Actas Urologicas Espanolas, Vol. 43, Núm. 9, pp. 455-466

  9. Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease

    Scientific Reports, Vol. 9, Núm. 1